I'm very confused with the relationship of Solexa and HiSeq.
Is it true that HiSeq 2000 based on the technology of Solexa?
Is it true that HiSeq 2000 based on the technology of Solexa?
-
-
Yes. They're both from illumina. Actually illumina bought solexa awhile back.
Solexa became GenomeAnalyzer. Then GenomeAnalyzer got a few upgrades (optics, flowcell layout, etc) until the GAIIx.
Then the hiseq came out. THe principals are the same, but they don't work the same way.
On the GA, the camera that takes pictures at given intervals, on the hiseq the camera does a linescan of the lanes of the flowcell.
The GA only reads the bottom of the flowcell, the hiseq reads top and bottom.
I won't list all the differences, you can go to illuminas site if you want more details.Last edited by lletourn; 05-12-2011, 08:18 AM. -
Thank you so muchComment
-
hello..
if i say solexa reads then it is considered Hiseq2000 based technology or not. actually i have solexa sequencing data and i installed the Fastx tool for adopter removal but this tool is only for solexa and sanger reads so i did not understand that solexa reads including HTseq technology or not.
thanx in advanceComment
-
Solexa was the name of the company that Illumina acquired back in 2006. Solexa pioneered the technology for sequencing that is still being used in principal with new Illumina sequencers.Originally posted by deepika123 View Post
Depending on the vintage of the data you are using there were multiple quality encoding formats (for fastq format). More information on that is here: http://en.wikipedia.org/wiki/FASTQ_format#Encoding
If you know that the data you have is using an older encoding method (i.e. "non-sanger" then you may have to pass right options to Fastx toolkit. If you are not sure what format your data is in (in terms of quality) then you can try the FastQC program: http://www.bioinformatics.babraham.a...ojects/fastqc/. It can generally identify the quality format and will display it in the general summary.
Trimmomatic is also a better option for trimming: http://www.usadellab.org/cms/?page=trimmomaticComment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment